These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 5016882)
1. Tubocurarine and renal failure. Gibaldi M; Levy G; Hayton WL Br J Anaesth; 1972 Feb; 44(2):163-5. PubMed ID: 5016882 [No Abstract] [Full Text] [Related]
2. Kinetics of the elimination and neuromuscular blocking effect of d-tubocurarine in man. Gibaldi M; Levy G; Hayton W Anesthesiology; 1972 Mar; 36(3):213-8. PubMed ID: 5011414 [No Abstract] [Full Text] [Related]
3. The pharmacokinetics of d-tubocurarine in man with and without renal failure. Miller RD; Matteo RS; Benet LZ; Sohn YJ J Pharmacol Exp Ther; 1977 Jul; 202(1):1-7. PubMed ID: 195035 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of 14C-dimethyl-d-tubocurarine in patients with normal renal function and terminal chronic renal failure (incl. anephric patients)]. Stoeckel H; Nold W Z Prakt Anasth Wiederbeleb Intensivther; 1972 Aug; 7(4):185-93. PubMed ID: 4664917 [No Abstract] [Full Text] [Related]
5. Renal function and the pharmacokinetics of neostigmine in anesthetized man. Cronnelly R; Stanski DR; Miller RD; Sheiner LB; Sohn YJ Anesthesiology; 1979 Sep; 51(3):222-6. PubMed ID: 382915 [No Abstract] [Full Text] [Related]
6. [Relaxometry. Methods and findings]. Kronschwitz H Anaesthesist; 1966 Mar; 15(3):88-91. PubMed ID: 5987381 [No Abstract] [Full Text] [Related]
7. [Cardiac or respiratory analeptics and curarization]. Cheymol J; Van den Driessche J; Allain P; Eben-Moussi E Anesth Analg (Paris); 1966; 23(1):121-32. PubMed ID: 4379354 [No Abstract] [Full Text] [Related]
8. Stimulus frequency is essential information. Ali HH; Savarese JJ Anesthesiology; 1979 Jan; 50(1):76-7. PubMed ID: 760617 [No Abstract] [Full Text] [Related]
9. Serum potassium concentrations after succinylcholine in patients with renal failure. Koide M; Waud BE Anesthesiology; 1972 Feb; 36(2):142-5. PubMed ID: 5059104 [No Abstract] [Full Text] [Related]
10. [2 years of exclusive use of diallyl-nor-toxiferine as relaxant in clinical anesthesia]. Chott F Anaesthesist; 1966 Mar; 15(3):81-3. PubMed ID: 5987377 [No Abstract] [Full Text] [Related]
11. [The role of diallyl-nor-toxiferin in the group of relaxants]. Ahnefeld FW; Halmágyi M Anaesthesist; 1966 Mar; 15(3):83-5. PubMed ID: 5987378 [No Abstract] [Full Text] [Related]
14. Binding of d-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Ghoneim MM; Kramer E; Bannow R; Pandya H; Routh JI Anesthesiology; 1973 Oct; 39(4):410-5. PubMed ID: 4758349 [No Abstract] [Full Text] [Related]
15. [On the ability to modify intestinal function by premedication and anesthesia]. Bergmann H Anaesthesist; 1965 Sep; 14(9):263-9. PubMed ID: 5865468 [No Abstract] [Full Text] [Related]
16. Safe reversal. 1. Atropine followed by neostigmine. An electrocardiographic study. Baraka A Br J Anaesth; 1968 Jan; 40(1):27-9. PubMed ID: 4866309 [No Abstract] [Full Text] [Related]
17. Studies of d-tubocurarine pharmacokinetics in humans and dogs. Ramzan IM; Shanks CA; Triggs EJ Anaesth Intensive Care; 1978 Feb; 6(1):30-5. PubMed ID: 665974 [TBL] [Abstract][Full Text] [Related]